Synairgen Share Discussion Threads

[toffeeman] 29/3/2020 11:13

1. Lit Het: Please accept my UNRESERVED apology - my humour muscles went into homogeneous paroxysm yesterday.

2. The Times don't always get it right "

Sunday December 30 2018
Our worst tip, however, came from Sabah Meddings, who put her money on AIM-listed Faron Pharmaceuticals. At the start of the year, it was close to revealing final data from trials of a treatment for a lung condition. Faron’s shares sank by 85% in one day when it revealed in May that the trial had been a disappointment. They ended the year down 93% at 56p."

I bought a few at 800 averaged down and exited with a small profit. I still hold a tiny amount bought at 60p and they have now recovered somewhat standing at 440p

[2nell] 29/3/2020 11:10

Many thanks for posting the article guys, and to you NG for your thread and input.

Stay safe everybody.

[mostro] 29/3/2020 10:49

Well done Nobbygnome, Thank for level headed post re IMM style risk.
I only wish I had seen your thread re concerns about Lupisor.. That debacle cost me many thousands of pounds. I will stay a little more vigilant here.

G L for a push next week.

[makendon] 29/3/2020 10:21

Anyone who has access to The Times could leave positive comments on the article
“Synairgen, a minnow surging ahead in the coronavirus fight”, to help get the word out.

[crookie3634] 29/3/2020 08:51

Was hoping to add more around the 40p Mark this week looking unlikely now! Think we have paused for breath and with the Times article likely to see us push north of 50p Monday morning. As the placing shares are already subscribed we shouldn’t expect anything to clear? I assume Friday RNS shares are also cleared now and maybe what kept driving the midday drops all of last week as they worked that sell.

[talk2dubya] 29/3/2020 08:49

In respect of Polar, it is not unusual
to see existing II’s sell some of their positions to allow new II’s on board.

Some of the larger trades have been X-OFF for example the 824k on Friday:



It should be an interesting week next week.

[talk2dubya] 29/3/2020 08:45

Don’t think I have ever seen a buy rec on the back of 35% percent discounted placing (still fuming) and a 300 percent rise before.

[hazl] 29/3/2020 08:45

Thanks everybody.
Also tidy and Makendon for posting it up very good.

[davew28] 29/3/2020 08:34

Also good news that Polar Capital are on board. Their funds are solid performers and Morning star ratings usually excellent depending on the fund manager.

[nobbygnome] 29/3/2020 08:31

I have already retired (very early) but it will change the nature of my retirement! I completely agree that a positive result will be life changing for all shareholders....and for the patients!

However, I am going to repeat this mantra time and time again. Don't be greedy; take some off the table before the results. If you are sceptical, look at what happened at IMM when the binary event went the wrong way in April 2018. The price went from 140p to 20p in 10 minutes.....

[lithological heterogeneities] 29/3/2020 08:27

Just the one word at the end sums it up...

BUY

What an absolutely astonishing opportunity to retire early should we get good results, as I expect based on the previous record of SNG001.

[nobbygnome] 29/3/2020 08:21

A buy reccomendation! That is what we need to get the placing indigestion out of the way. Excellent news!

[dave444] 29/3/2020 08:17

Monday should be a good day!

[dave444] 29/3/2020 08:15

Great article Tidy!

[makendon] 29/3/2020 08:11

Thanks tidy2

#msg-1234

The Times article;

As the world’s top scientists and drugs giants strive to develop vaccines and experimental drugs to fight Covid-19, a little-known British company is already racing to the front line.

Synairgen, listed on the London Stock Exchange and worth just £50m, is starting a clinical trial in hospitals across the UK with a drug it hopes will prevent coronavirus sufferers from falling seriously ill.

Synairgen’s technology uses a naturally occurring protein known as interferon beta, which orchestrates the body’s antiviral response. It is used as a treatment for multiple sclerosis.

Synairgen’s team of experts has turned it into a drug that can be delivered through an inhaler. By boosting the lung’s defence mechanisms, it is hoped the drug — known as SNG001 — will prevent patients from developing severe lower respiratory tract illnesses caused by infections such as Covid-19. Phase II trials in patients with asthma have already shown that it enhances the lung’s antiviral defences.

Synairgen will now test the treatment on 100 patients with coronavirus. Half will be given its new drug, half will get a placebo. Results could arrive in as soon as eight weeks, which could pave the way for a fast-tracked pivotal study in a bigger group of patients and rapid approval.

A treatment could finally bring success for Synairgen. Since listing in 2004, its shares had fallen more than 95% — hit by a lack of funding and an overhang from investors including fallen stockpicker Neil Woodford. While shares in most of Britain’s biggest companies have taken a hammering since the outbreak began, Synairgen’s have climbed more than 300%, closing on Friday at 46p and giving the company a value of £50.3m.

The run gave Synairgen the confidence last week to announce a £14m share placing, which brought in new investors including Polar Capital, while hedge fund Lansdowne increased its holding.

Directors also bought shares, which were issued at 35p each — a 32% discount to the closing price on the day before the placing was announced. The new money will provide enough cash to complete the trial and start manufacturing the drug, should it be approved.

For patients with pre-existing health conditions such as asthma, who are more at risk of complications from Covid-19, Synairgen could be on to a key treatment. Clinical trials are notoriously high-risk, but existing data shows its drug is well tolerated. Synairgen should have a part to play in the fightback against the pandemic. Buy.

[talk2dubya] 29/3/2020 07:55

With you on that my wife is early days pregnant with number 2 and they say you don’t worry as much with number 2!

I see there was some bad news in the states yesterday on that front. We will all be lucky to escape this without it impacting someone close to us it’s very sad.

[tidy 2] 29/3/2020 02:33

The TimesHTTPS://www.thetimes.co.uk/edition/business/synairgen-a-minnow-surging-ahead-in-the-coronavirus-fight-f85q2wlh0

[dealer55] 28/3/2020 21:32

That’s awful. I have a 5 month old and was discussing with my wife how pregnancy is a worrying time adding this new world to is unthinkable my heart goes out to anyone in this situation. Al the best to them good luck.

[talk2dubya] 28/3/2020 20:49

I saw someone posted the other day that they had split the placing in two, in case they got a bid. The reason is that they don’t have the right to allot more shares than in the firm placing hence why it is split in two.

They could have quite easily arranged for shareholders to participate in the conditional funding, given the time it will take to get shareholder approval.

Notwithstanding the 90 day limit above is interesting.

[talk2dubya] 28/3/2020 20:46

As part of the Placing, the Company has agreed that it will not for a period of 90 days after (but including) Admission, directly or indirectly, issue, offer, sell, lend, pledge, contract to sell or issue, grant any option, right or warrant to purchase or otherwise dispose of any Ordinary Shares (or any interest therein or in respect thereof) or other securities of the Company exchangeable for, convertible into or representing the right to receive Ordinary Shares or any substantially similar securities or otherwise enter into any transaction (including derivative transaction) directly or indirectly, permanently or temporarily, to dispose of any Ordinary Shares or undertake any other transaction with the same economic effect as any of the foregoing or announce an offering of Ordinary Shares or any interest therein or to announce publicly any intention to enter into any transaction described above. This agreement is subject to certain customary exceptions and does not prevent the grant or exercise of options under any of the Company's existing share incentives and share option schemes, or following Admission the issue by the Company of any Ordinary Shares upon the exercise of any right or option or the conversion of a security already in existence.

[dealer55] 28/3/2020 20:34

Any predictions for next week then. And when do we fee the updates will flow from trials. As we progress or at the end. Needs to happen fast, if someone can master cure and testing we can look at getting our lives back and stopping the global horrific death toll.

[nobbygnome] 28/3/2020 19:55

>> ohisay

Obviously it depends on the terms of the deal but it could be more than 5p. It would be somewhat ironic if there was say a £50 million upfront of which SNG would get £8.5 million as that would have negated the need for a fund raising!